Two doctors have resigned from a prestigious panel after FDA approved a controversial Alzheimer's drug

Two top neuroscience experts have resigned from posts advising the US Food and Drug Administration following the agency’s controversial approval of a new Alzheimer’s disease drug. Dr. David Knopman, a neurologist at the Mayo Clinic and member of the FDA’s Peripheral and Central Nervous System Drugs …

Read more

Show More

Related Articles

Back to top button